ozempic vs tirzepatide Why You Might Tolerate One Weight Loss Drug Better Than Another The infographic compares 10 commonly

CagriSema combines semaglutide with cagrilintide (an amylin receptor agonist), targeting yet another hormone pathway involved in appetite regulation

Semaglutide is a long-acting GLP-1 receptor agonist with structural homology to native human GLP-1

Factors that may influence perioperative management include: Medication characteristics : Daily GLP-1 medications (liraglutide, oral semaglutide) have shorter durations of action than weekly formulations (injectable semaglutide, dulaglutide, exenatide extended-release) [3] Risk factors : Higher doses, recent dose increases, active gastrointestinal symptoms, or known gastroparesis may increase risk [1] [3] Procedure type : More complex surgeries or those requiring general anaesthesia may warrant different approaches than minor procedures Individual patient factors : BMI, presence of diabetes, and other medical conditions Some anaesthetists may recommend temporarily pausing GLP-1 therapy before certain procedures, particularly for patients with additional risk factors

Peptide therapy is generally well-tolerated when administered under professional supervision

Semaglutide for managing overweight and obesity (TA875) Chapter 1: Recommendations

Those who were overweight or obese and taking the drug to lose weight were seven times more at risk